Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ADREXpharma
Koblenz, Rhineland-Palatinate, Germany
- Ownership
- Private
- Development stage
- Other
01
Overview
ADREXpharma offers a portfolio of medical cannabis products (cannabis flowers, extracts, dronabinol, cannabis-based compounded medicines) distributed to pharmacies across Germany, with a focus on pharmaceutical quality, regulatory compliance, and innovation in formulation and application development. The company drives innovation through products like its rapid THC detection kit for pharmacies and maintains partnerships to ensure GMP-compliant supply chain integrity[2][4][6][8].
- Therapeutic areas
- GastroenterologyNeurologyOther
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
MediPharm LabsMother LabsPideka
Beyond the preview
Go deeper on ADREXpharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ADREXpharma.